Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 citing Larsen: Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting.... (0.06 sec) 

Enhancing incretin action for the treatment of type 2 diabetes

- diabetesjournals.org
DJ Drucker - Diabetes Care, 2003 - Am Diabetes Assoc
RESULTS—Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic
peptide (GIP) exert important effects on β-cells to stimulate glucose-dependent
insulin secretion. Both peptides also regulate β-cell proliferation and ...
Cited by 283 - Related articles - All 13 versions

The gut and energy balance: visceral allies in the obesity wars

- stanford.edu [PDF] 
MK Badman, JS Flier - Science, 2005 - sciencemag.org
In addition to digesting and assimilating nutrients, the intestine and
associated visceral organs play a key sensing and signaling role in the
physiology of energy homeostasis. The gut, the pancreatic islets of ...
Cited by 161 - Related articles - All 14 versions

The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell …

- physiology.org
B Rolin, MO Larsen, CF Gotfredsen, CF … - American Journal of Physiology- Endocrinology And …, 2002 - Am Physiological Soc
NN2211 is a long-acting, metabolically stable glucagon-like peptide-1 (GLP-1)
derivative designed for once daily administration in humans. NN2211 dose
dependently reduced the glycemic levels in ob/ob mice, with ...
Cited by 128 - Related articles - BL Direct - All 4 versions

Development and characterization of a glucagon-like peptide 1-albumin conjugate


JG Kim, LL Baggio, DP Bridon, JP Castaigne, … - Diabetes, 2003 - Am Diabetes Assoc
The rapid degradation of native glucagon-like peptide 1 (GLP-1) by dipeptidyl
peptidase-IV (DPP-IV) has fostered new approaches for generation of
degradation-resistant GLP-1 analogues. We examined the biological activity ...
Cited by 126 - Related articles - BL Direct - All 5 versions

Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food …

- physiology.org
SC Woods - American Journal of Physiology- Gastrointestinal and …, 2004 - Am Physiological Soc
An overview is presented of those signals generated by the gastrointestinal (GI)
tract during meals that interact with the central nervous system to create a
sensation of fullness and satiety. Although dozens of enzymes, hormones, ...
Cited by 119 - Related articles - All 7 versions

Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes


DJ Drucker - eid, 2003 - informahealthcare.com
Incretins are peptide hormones, exemplified by glucose-dependent insulino-
tropic peptide and glucagon-like peptide 1 that are released from the gut in
response to nutrient ingestion and enhance glucose-stimulated insulin ...
Cited by 118 - Related articles - All 6 versions

Peripheral oxyntomodulin reduces food intake and body weight gain in rats

- endojournals.org
CL Dakin, CJ Small, RL Batterham, NM Neary … - Endocrinology, 2004 - Endocrine Soc
Oxyntomodulin (OXM) is a circulating gut hormone released post prandially from
cells of the gastrointestinal mucosa. Given intracerebroventricularly to rats,
it inhibits food intake and promotes weight loss. Here we report that ...
Cited by 114 - Related articles - BL Direct - All 9 versions

The inhibitory effects of peripheral administration of peptide YY3–36 and glucagon-like …


CR Abbott, M Monteiro, CJ Small, A Sajedi, … - Brain Research, 2005 - Elsevier
The vagus nerve forms a neuro-anatomical link between the gastrointestinal tract
and the brain. A number of gastrointestinal hormones, including cholecystokinin
and ghrelin, require an intact vagal–brainstem–hypothalamic pathway to ...
Cited by 100 - Related articles - All 3 versions

A recombinant human glucagon-like peptide (GLP)-1–albumin protein (albugon) mimics …

- diabetesjournals.org
LL Baggio, Q Huang, TJ Brown, DJ Drucker - Diabetes, 2004 - Am Diabetes Assoc
Peptide hormones exert unique actions via specific G protein–coupled
receptors; however, the therapeutic potential of regulatory peptides is
frequently compromised by rapid enzymatic inactivation and clearance from ...
Cited by 94 - Related articles - BL Direct - All 11 versions

The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic …

- Free from Publisher
H Harder, L Nielsen, TDT Thi, A Astrup - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—After 8 weeks, liraglutide reduced fasting serum glucose (liraglutide,
−1.90 mmol/l, and placebo, 0.27 mmol/l; P = 0.002) and HbA 1c (liraglutide,
−0.33%, and placebo, 0.47%; P = 0.028) compared with placebo. No change ...
Cited by 89 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google